WHO WE ARE

Creative Medical Technology Holdings, Inc.

Ticker Symbol CELZ

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company committed to improving patient lives in the areas of Urology, Neurology and Orthopedics.

Since 2011, Creative Medical Technology Holdings, Inc. (CELZ) and our affiliate company Creative Medical Health, Inc. have focused on regenerative medical solutions for unmet Urological, Neurological and Orthopedic needs. We have developed an extensive intellectual property portfolio utilizing stem cells for the treatment of multiple indications and commercialized complete patented and trademarked protocols for erectile dysfunction under the CaverStem® brand and the FemCelz® brand for the treatment of female sexual dysfunction. Our StemSpine® technology will be launched in the near future. CELZ is also breaking new ground with its AmnioStem™ technology for the for treating strokes, using our patented amniotic fluid-based stem cell. Our team consists of leading international physicians and scientists specializing in regenerative medicine. Our “science-first” approach to procedures ensures that all of our technology are proven to be both safe and effective.

The Creative Medical Technology Holdings Difference
  • Commercialized Procedures (CaverStem® and FemCelz®)

  • Extensive Patent Portfolio

  • Key Relationships With Leading Scientists and Physicians

  • Validated Safety and Efficacy

Intellectual Property

Creative Medical Technology Holdings has developed/acquired a robust intellectual property (IP) portfolio related to the utilization of stem cells to improve patient lives in the areas of Urology, Neurology and Orthopedics.

This IP portfolio positions us at the forefront of the regenerative medicine industry (set to grow to $39Bn by 2023). We plan to commercialize these products on our own and in collaboration with strategic partners.

Areas Patent Description
Urology US20170290887A1 Cell Based Therapy for Female Sexual Dysfunction
Urology US20180015127A1 Methods for Treatment of Premature Ovarian Failure and Ovarian Aging Using Regenerative Cells
Urology US20170354686A1 Adipose Derived Immunomodulatory Cells for Immunotherapy of Recurrent Spontaneous Abortions
Urology US8372797B2 Treatment of Erectile Dysfunction by Stem Cell Therapy
Urology US20180325959A1 Methods of Treating Erectile Dysfunction Using Regenerative Cells and Therapeutic Energy Treatments
Urology US20180334664A1 Regeneration of Corpus Cavernosal Tissue
Neurology US20180071342A1 Inducing and accelerating post-stroke recovery by administration of amniotic fluid derived stem cells
Neuro/Oncology US20190022147A1 Treatment of Glioma by Amniotic Fluid Stem Cells and Exosomes Derived Thereof
Neurology US20180340145A1 Generation of Autologous Immune Modulatory Cells for Treatment of Neurological Conditions
Neurology US20180133258A1 Treatment of Cachexia Using Stem Cells and Products Thereof
Stem Cells US7569385B2 Multipotent Amniotic Fetal Stem Cells
Orthopedics US20180344899A1 Enhancement of Nucleus Pulposus Regeneration by Enhanced Perfusion of Perispinal Area by Combination Drug, Gene and Cellular Therapies
Orthopedics US20180360882A1 Perispinal Perfusion by Administration of T Regulatory Cells Alone or in Combination with Angiogenic Cell Therapies
Orthopedics US9598673B2 Treatment of Disc Degenerative Disease

Timothy Warbgington

Chief Executive Officer

Donald Dickerson

Chief Financial Officer

Thomas Ichim PhD

Chief Scientific Officer

Timothy Warbington

Donald Dickerson

Thomas Ichim PhD

Amit Patel MS MD

Timothy Henry  MD

Director of Cardiology, Cedars-Sinai Heart Institute. Dr. Henry’s experience also includes Director of Research at Minneapolis Heart Institute Foundation.

Eric Duckers MD PhD

Assistant Professor, Erasmus Medical Center, Head, Molecular Cardiology Laboratory, Erasmus Medical Center and Interventional Cardiologist, Erasmus Medical Center, Rotterdam, Netherlands.

Santosh Kesari, MD, PhD

Director, Neuro-oncology;  Chair and Professor, Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute

Amit Patel MS MD

Cardiac surgeon, former Associate
Professor and Director of Clinical
Regenerative Medicine and Tissue
Engineering at the University of Utah.
Dr. Patel has pioneered break-through therapies using stem cells and is a world leader in stem cell therapies.

Our Pipeline
Product
Description
Preclinical
Clinical
Pilot
In-Market

CaverStem®

Regenerative Stem Cell Procedure for Treatment of Erectile Dysfunction in Men

FemCelz®

Regenerative Stem Cell Procedure for Treatment of Female Sexual Dysfunction

StemSpine®

Regenerative Stem Cell Procedure for Treatment of Degenerative Disc Disease

AmnioStem™

Amniotic Fluid Derived Stem Cells for Treatment of Stroke

CAREERS

At Creative Medical Technology Holdings, our team is committed to unlocking the full potential of regenerative medicine to improve human health.

We are always looking for talented individuals to join us in this mission.
To be considered, please email your resume to

CEO@CreativeMedicalHealth.com

Contact Us